Telehealth made it easier to see a psychiatrist. January 2022. This is when Medicare-reimbursed telepsychiatry arrangements became everlasting.
The idea behind these video and phone consultations was to supply more flexible and early appointment times without the necessity to travel.
But Our new analysis Shows what happened next.
We show how telepsychiatry is dominated by stimulant prescription advice from 2022. These were mostly for individuals with attention deficit hyperactivity disorder or ADHD.
Telepsychiatry for ADHD increased access, especially for people living in rural and distant areas. But it was more prone to be provided by psychiatrists living in wealthier larger towns and cities.
These sorts of ADHD telepsychiatry appointments are also increasingly associated. Out-of-pocket expenses Compared to equivalent face-to-face meetings.
A triple jump in ADHD scripts
We reviewed nearly 4 million Medicare Benefits Schedule records for psychiatric consultations between 2017 and 2023.
Before COVID, our study found that fewer than one in 20 psychiatric consultations were linked to an ADHD prescription, and one in 50 were done via video.
By 2022, the variety of ADHD-related prescriptions nearly tripled from 4.3% to 11.8%. About one in 4 video psychiatric consultations were linked to stimulant prescriptions.
Prescriptions for other psychiatric conditions related to video counseling barely moved over the identical period, and in some cases fell.
This increase in ADHD scripts through telehealth just isn’t just because more persons are being diagnosed with ADHD overall, although that can be true. Data from the Australian Institute of Health and Welfare show Between 2004-05 and 2023-24, the availability of ADHD drugs increased nearly elevenfold.
We found that the rise in psychiatric appointments generated by telehealth was largely accounted for by ADHD diagnoses. Specifically, these are the sorts of appointments that end with a brand new prescription slightly than ongoing follow-up care.
Who is proposing and where?
Our one Previous papers It explains how telepsychiatry helps address the shortage of psychiatrists in rural areas.
We subsequently initially expected that ADHD prescribing via telepsychiatry could be concentrated amongst psychiatrists working in underserved, regional and distant areas – clearly designed to achieve patients telehealth.
However, the best increase in ADHD prescribing was provided by psychiatrists practicing in Australia’s most socioeconomically advantaged postcodes. About half of all psychiatrists in our dataset resided within the wealthiest areas. The group cited video as a significant contributor to the rise in ADHD prescriptions.
This is vital because video ADHD counseling, on average, Patients incur more out-of-pocket costs. Compared to an equal face-to-face encounter.
So the image is less about improving access to telepsychiatry and removing the fee barrier to care. It’s about creating better-paying specialist services for individuals who can already afford them.
Why ADHD, specifically?
Interest in ADHD, and its diagnosis, has exploded for several reasons.
Social media has allowed more people to acknowledge their ADHD-like symptoms, especially adults who were never diagnosed as children.
Search terms like “ADHD treatment” and “ADHD medication” Steadily climbed throughout the study period. We observed this online interest closely with the rise in video prescribing of stimuli.
Others point to social media platforms, digital notifications, emails and algorithmic content that tax the brain, making it difficult to focus for long periods of time. it”The attention economy“, he says, can even contribute to people pondering they’ve ADHD and looking for a diagnosis.
When services for ADHD dominate, others will miss out.
None of which means the demand is not real, or that the valuations are incorrect. In drug treatment for ADHD a Strong evidence base And life can change.
This change was strongly related to the next proportion of female patients with ADHD. Historically underrecognized.
But these video ADHD suggestions might be profitable. They offer psychiatrists a approach to see more patients faster. So a single “one-time” assessment of half-hour or in order that leads to a script – of the sort we have identified – is a sexy business model.
When ADHD telehealth involves dominate Medicare funding that was originally designed to broaden access to all psychiatric care, market access for individuals with other mental illnesses could also be lost.
So yes, telepsychiatry is expanding access. But our study shows that its model is targeted on a single, profitable, fast-growing diagnostic and prescription business.
What does this mean as GPs prepare to step in?
Until recently, in most of Australia only psychiatrists could diagnose and begin ADHD medication for adults.
But in response to difficulty accessing psychological counselling, state governments are moving to permit GPs to diagnose and prescribe ADHD.
Although this seems sensible, we could be concerned if we in telepsychiatry saw similar problems basically practice. Namely, the increased commoditization of ADHD care.